thyroxine has been researched along with Demyelinating Diseases in 3 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Delay in thyroxine therapy in newborns with congenital hypothyroidism leads to irreversible brain damage." | 9.08 | Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. ( Jagannathan, NR; Kochupillai, N; Raghunathan, P; Tandon, N, 1998) |
| " Delay in thyroxine therapy in newborns with congenital hypothyroidism leads to irreversible brain damage." | 5.08 | Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. ( Jagannathan, NR; Kochupillai, N; Raghunathan, P; Tandon, N, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weinstock-Guttman, B | 1 |
| Zivadinov, R | 1 |
| Horakova, D | 1 |
| Havrdova, E | 1 |
| Qu, J | 1 |
| Shyh, G | 1 |
| Lakota, E | 1 |
| O'Connor, K | 1 |
| Badgett, D | 1 |
| Tamaño-Blanco, M | 1 |
| Tyblova, M | 1 |
| Hussein, S | 1 |
| Bergsland, N | 1 |
| Willis, L | 1 |
| Krasensky, J | 1 |
| Vaneckova, M | 1 |
| Seidl, Z | 1 |
| Ramanathan, M | 1 |
| Jagannathan, NR | 1 |
| Tandon, N | 1 |
| Raghunathan, P | 1 |
| Kochupillai, N | 1 |
| Takeda, K | 1 |
| Sakuta, M | 1 |
| Saeki, F | 1 |
1 trial available for thyroxine and Demyelinating Diseases
| Article | Year |
|---|---|
Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study.
Topics: Adolescent; Adult; Brain; Brain Chemistry; Child; Congenital Hypothyroidism; Demyelinating Diseases; | 1998 |
2 other studies available for thyroxine and Demyelinating Diseases
| Article | Year |
|---|---|
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
Topics: Adjuvants, Immunologic; Adult; Body Mass Index; Brain; Calcifediol; Cholesterol; Cholesterol, HDL; C | 2013 |
Central pontine myelinolysis diagnosed by magnetic resonance imaging.
Topics: Brain Diseases; Demyelinating Diseases; Drug Therapy, Combination; Female; Fludrocortisone; Humans; | 1985 |